Summit Securities Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-35,000
Closed -$220K 829
2022
Q4
$220K Hold
35,000
0.01% 462
2022
Q3
$241K Hold
35,000
0.02% 390
2022
Q2
$293K Hold
35,000
0.04% 256
2022
Q1
$800K Buy
35,000
+10,000
+40% +$244K 0.09% 165
2021
Q4
$690K Buy
+25,000
New +$669K 0.03% 303

Other funds holding BHC

Summit Securities Group's BHC Position: Q4 2025 in Review

Summit Securities Group sold out of Bausch Health (BHC) in Q4 2025, closing a stake of 1,831 shares — an estimated $11.8K sold.

Summit Securities Group first reported a position in BHC in Q2 2015 and held it in 5 quarters. The position peaked at $552K in Q4 2021. 235 funds tracked by Wall St. Rank hold BHC as of Q4 2025.

  • Summit Securities Group reported no remaining Bausch Health position as of Q4 2025 after selling out during the quarter.
  • Summit Securities Group sold 1,831 Bausch Health shares in Q4 2025, an estimated $11.8K.
  • Summit Securities Group first reported a position in Bausch Health in Q2 2015 and held it in 5 quarters.
  • Summit Securities Group's Bausch Health position peaked at $552K in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Bausch Health as of Q4 2025.

Based on Summit Securities Group's 13F filing for Q4 2025, filed 17 Feb 2026.